AUVI News and Press, Applied UV Inc. From 12/01/21

Applied UV (NASDAQ:AUVI) +47%. Skylight Health Group (NASDAQ:SLHG) +27%. Ardelyx (NASDAQ:ARDX) +18%. IceCure Medical (NASDAQ:ICCM) +17%. Energy Focus (NASDAQ:EFOI) +17%. Ambarella (NASDAQ:AMBA) +15% on Q3 results VBI Vaccines (NASDAQ:VBIV) +14% wins FDA approval for Hepatitis B vacc...

AFRIMS to install Airocide® technology to protect visitors and staff AFRIMS is a biomedical research facility of the U.S. Army's Walter Reed Army Institute of Research MOUNT VERNON, NY / ACCESSWIRE / December 1, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or th...

Gainers: Biofrontera (NASDAQ:BFRI) +154%. Longeveron (NASDAQ:LGVN) +79%. Ocuphire Pharma (NASDAQ:OCUP) +36%. Society Pass (NASDAQ:SOPA) +24%. Biofrontera (NASDAQ:BFRA) +23%. Better Therapeutics (NASDAQ:BTTX) +20%. Applied UV (NASDAQ:AUVI) +19%. Standard Lithium (NYSE:SLI) +19%. Blue Star Food...

Gainers: Grom Social Enterprises (NASDAQ:GROM) +17%. Spark Networks (NYSE:LOV) +19%. Applied UV (NASDAQ:AUVI) +17%. Engine Gaming and Media (NASDAQ:GAME) +16%. RLX Technology (NYSE:RLX) +14%. Losers: Nordstrom (NYSE:JWN) -29%. The Gap (NYSE:GPS) -22%. Dillard's (NYSE:DDS) -9%. Allie...

Applied UV, Inc. (AUVI) Q3 2021 Earnings Conference Call November 16, 2021 09:00 ET Company Participants Kevin McGrath - Investor Relations Keyo Saeed - Chief Executive Officer Mike Riccio - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Presentation O...

Applied UV (NASDAQ:AUVI): Q3 GAAP EPS of -$0.14 misses by $0.01. Revenue of $3.55M (+127.6% Y/Y) beats by $0.65M. Press Release For further details see: Applied UV EPS misses by $0.01, beats on revenue

Results: Revenue increased 88.5% to $3.55 million as compared to $1.88 in the previous quarter Gross profit increased to $1.0 million, or 29.6% vs. sales as compared to $0.5m, or 28.3% vs. sales in the previous quarter Net loss improved 49% to $(1,080,805) as compared to a ...

MOUNT VERNON, NY / ACCESSWIRE / November 11, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air puri...

The following replaces and corrects the release issued on October 19, 2021: Candida Auris is a pathogenic disease commonly acquired in hospitals or long-term care facilities Centers for Disease Control and Prevention ("CDC") has stated that 30-60% of people with C. auris bloodstream ...

Candida Auris is a pathogenic disease commonly acquired in hospitals or long-term care facilities Centers for Disease Control and Prevention ("CDC") has stated that 30-60% of people with C. auris bloodstream infections die CDC currently considers Candidiasis as one of the most signi...